<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01409083</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-11-8207-IK-CTIL</org_study_id>
    <nct_id>NCT01409083</nct_id>
  </id_info>
  <brief_title>Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Children</brief_title>
  <official_title>Evaluating the Use of Intravenous Bicarbonate as a Tool to Verify the Intravascular Position of an IV Catheter in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tel Aviv University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sodium bicarbonate injected into a blood vessel transforms to carbon dioxide and water. The
      increase in carbon dioxide production can be detected by measuring the exhaled carbon dioxide
      in the lungs.

      This study is conducted to access the clinical application of measuring exhaled carbon
      dioxide to verify the correct position of intravenous catheters.Once the catheter is in the
      correct position the injected bicarbonate will be detected as a distinct elevation of exhaled
      carbon dioxide. A similar study was already performed in adults and was found useful. The
      investigators now extend the clinical application to children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Extravasation is the unintentional injection or leakage of fluids into the perivascular or
      subcutaneous space resulting in potential tissue injury. This prospective controlled study,
      will assesse the diagnostic utility of using intravenous diluted sodium bicarbonate to
      confirm placement of intravenous (IV) catheters in ventilated children. Diluted sodium
      bicarbonate will be created using undiluted standard 8.4% (1 meq/mL) sodium bicarbonate mixed
      in a 1:3 ratio with sterile water to achieve a final diluted concentration of 2.1% (0.25
      mEq/mL). In 20 ASA I-II mechanically ventilated children age 2-8 years, the effects of 1
      ml/kg of diluted 2.1% sodium bicarbonate or 0.9% normal saline,injected in a randomized
      order, will be analyzed. All children will have venous blood samples taken prior to injection
      and 10 minutes after injection for analysis of venous blood pH and electrolytes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>increase in exhaled carbon dioxide</measure>
    <time_frame>0.5-10.00 seconds</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Verifying the Correct Position of Intravenous Catheters</condition>
  <arm_group>
    <arm_group_label>intravenous bicarbonate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diluted sodium bicarbonate will be injected to s new IV catheter expecting a rise in end-tidal CO2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>equal volume of normal saline will be randomely injected</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>intravenous sodium bicarbonate</intervention_name>
    <description>Dilted sodium bicarbonate 2.1%</description>
    <arm_group_label>intravenous bicarbonate</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I,II

          -  age 2-8 years

        Exclusion Criteria:

          -  ASA III or higher
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52361</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2011</study_first_submitted>
  <study_first_submitted_qc>August 2, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2011</study_first_posted>
  <last_update_submitted>December 11, 2012</last_update_submitted>
  <last_update_submitted_qc>December 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Dr. Ilan Keidan</investigator_full_name>
    <investigator_title>director of pediatric anesthesia</investigator_title>
  </responsible_party>
  <keyword>infiltration</keyword>
  <keyword>extravasation</keyword>
  <keyword>end-tidal carbon dioxide</keyword>
  <keyword>sodium bicarbonate</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

